AAP
NUVB icon

Arax Advisory Partners’s Nuvation Bio NUVB Stock Holding History

Arax Advisory Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36
Closed -$323 – 4166
2025
Q4 		$323 Sell
36
-39,275
-100% -$243K ﹤0.01% 3664
2025
Q3 		$145K Buy
+39,311
New +$107K ﹤0.01% 1389
2025
Q1 		– Sell
-234
Closed -$623 – 2927
2024
Q4 		$623 Hold
234
– – ﹤0.01% 2278
2024
Q3 		$536 Hold
234
– – ﹤0.01% 2391
2024
Q2 		$684 Buy
+234
New +$714 ﹤0.01% 2274

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arax Advisory Partners's NUVB Position: Q1 2026 in Review

Arax Advisory Partners sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 36 shares — an estimated $323 sold.

Arax Advisory Partners first reported a position in NUVB in Q2 2024 and held it in 5 quarters. The position peaked at $145K in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Arax Advisory Partners reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Arax Advisory Partners sold 36 Nuvation Bio shares in Q1 2026, an estimated $323.
  • Arax Advisory Partners first reported a position in Nuvation Bio in Q2 2024 and held it in 5 quarters.
  • Arax Advisory Partners's Nuvation Bio position peaked at $145K in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.